JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(4):190-199

The effect of polymeric dispersion type on the release of diclofenac sodium from coated pellets

K. Krejčová1, M. Rabišková1, D. Vetchý1, V. Tomášek2, A. Prokopová2
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků
2 Zentiva, a. s. Praha

Recently, coated pellets have gained attention of the pharmaceutical industry as they represent a relatively easy way leading to controlled drug release. Pellets of appropriate properties containing approx. 40 % of diclofenac sodium were prepared by roto-agglomeration. For the coating, two different aqueous dispersions (Surelease® and Eudragit®RS 30 D) were selected. Generally, the drug release rate slowed down as the coating load increased from 10 to 22 %. However, big differences between diclofenac sodium release from pellets coated with Surelease® and Eudragit®RS30D at equivalent coating loads were observed. Although Eudragit®RS 30 D provided membranes successfully controlling drug release over an extended period of 24 hours, the coating process with Surelease® led to a film of a very poor quality. Faster release from ethyl cellulose coated pellets could be explained in terms of a higher solubility of diclofenac sodium in alkaline aqueous dispersion of ethyl cellulose and its migration into the coat during the coating process and/or the unsatisfactory curing of the ethyl cellulose film. Therefore possible interactions between the coating and the drug should be always considered as suggested in this study.

Keywords: coated pellets; diclofenac sodium; Surelease®; Eudragit® RS 30 D

Received: May 27, 2007; Accepted: June 28, 2007; Published: April 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejčová K, Rabišková M, Vetchý D, Tomášek V, Prokopová A. The effect of polymeric dispersion type on the release of diclofenac sodium from coated pellets. Čes. slov. farm. 2007;56(4):190-199.
Download citation

References

  1. Rowe, R. C.: Pharm. Techn. Eur., 1996; 8, 48-52. Go to original source... Go to PubMed...
  2. Cole, G. C.: Coating Pans and Coating Columns. In: Cole, G. C., Hogan, J., Aulton, N. eds. Pharmaceutical Coating Technology. Londýn, Taylor & Francis Ltd., 1995.
  3. Seitz, J. A.: Aqueous film coating. In: Swarbrick, J., Boylan, J.C. eds. Encyclopedia of Pharmaceutical Technology, 1. vyd. New York, Marcel Dekker, Inc., 1991.
  4. Bauer, K. H. et al.: Coated Pharmaceutical Dosage Forms. Stuttgart, Medpharm Scientific Publishers, 1998, s. 280.
  5. Jones, D. M.: Solution and Suspension Layering. In: Ghebre-Sellassie, I. ed. Pharmaceutical Pelletization Technology, 1. vyd. New York, Marcel Dekker, Inc., 1989.
  6. Christensen, F. N., Bertelsen, P.: Drug Dev. Ind. Pharm., 1997; 25, 451-463. Go to original source...
  7. Fukumori, Y.: Coating of multiparticulates using polymeric dispersios: Formulation and process considerations. In. Ghebre-Sellassie, I. ed. Multiparticulate Oral Drug Delivery, New York, Marcel Dekker, Inc., 1994. Go to original source...
  8. Wu, T. et al.: Drug Dev. Ind. Pharm., 2000; 26, 95-102. Go to original source... Go to PubMed...
  9. Jones, D. M.: Air suspension coating. In: Swarbrick, J., Boylan, J.C. eds. Encyclopedia of Pharmaceutical Technology, 1. vyd. New York, Marcel Dekker, Inc., 1991.
  10. Im-Emsap, W., Siepmann, J., Paeratakul, O.: Disperse Systems. In: Banker, G., Rhodes, Ch. eds. Modern Pharmaceutics, 4. vyd. New York, Marcel Dekker, Inc., 2002. Go to original source...
  11. Chung, T. W. et al.: J. Microencapsulation, 2002; 19, 463-471. Go to original source... Go to PubMed...
  12. Lehmann, K.: Coating of multiparticulates using polymeric solution. In: Ghebre-Sellassie, I. ed. Multiparticulate Oral Drug Delivery, New York, Marcel Dekker, Inc., 1994. Go to original source...
  13. Guteérrez-Rocca, J., McGinity, J. W.: Int. J. Pharm., 1994; 103, 293-301. Go to original source...
  14. Wang, Ch. Ch. et al.: Int. J. Pharm., 1997; 152, 153-163. Go to original source...
  15. Okarter, T. U., Singla, K.: Drug Dev. Ind. Pharm., 2000; 26, 323-329. Go to original source... Go to PubMed...
  16. Radebaught, G. W.: Film coatings and film-forming materials:Evaluation. In: Swarbrick, J., Boylan, J.C. eds. Encyclopedia of Pharmaceutical Technology, New York, Marcel Dekker, Inc., 1991.
  17. Wu, Ch., McGinity, J. W.: Int. J. Pharm., 1999; 177, 15-27. Go to original source... Go to PubMed...
  18. Heinämäki, J. T. et al.: Int. J. Pharm., 1994; 112, 191-196. Go to original source...
  19. Wu, Ch., McGinity, J. W.: Int. J. Pharm., 2000; 150, 277-284.
  20. Rhodes, C. T., Porter, S. C.: Drug Dev. Ind. Pharm., 1997; 24(12), 1139-1154. Go to original source... Go to PubMed...
  21. Chan, L. W., Chan, W. Y., Heng, P. W. S.: Int. J. Pharm., 2001; 213, 63-74. Go to original source... Go to PubMed...
  22. Béchard, S. R., Quaraishi, S. R., Kong, E.: Int. J. Pharm., 1992; 82, 133-139. Go to original source...
  23. Maul, K. A., Schmidt, P. C.: Int. J. Pharm., 1995; 118, 103-112. Go to original source...
  24. Vertommen J., Kinget, R.: Drug Dev. Ind. Pharm., 1997; 23, 39-46. Go to original source...
  25. Sadeghi, F. et al.: Drug Dev.Ind.Pharm., 2000; 26, 651-660. Go to original source... Go to PubMed...
  26. Sadeghi, F. et al.: Drug Dev.Ind.Pharm., 2001; 27, 419-430. Go to original source... Go to PubMed...
  27. Sadeghi, F., Ford, J. L., Rajabi-Siahboomi, A.: Int. J. Pharm., 2003; 254, 123-135. Go to original source... Go to PubMed...
  28. Donbow, M.: Microcapsules and Nanoparticles in Medicine and Pharmacy. Boca Raton - Ann Arbor - London, CRC Press, 1991, s. 347.
  29. Lorck, C. A. et al.: Eur. J..Pharm. Biopharm., 1997; 43, 149-157. Go to original source...
  30. McConnell, E. et al.: Cellulose, 2007; 14, 25-34. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.